S&P 500   3,766.78 (-0.04%)
DOW   31,007.17 (+0.27%)
QQQ   302.40 (-0.56%)
AAPL   119.24 (-0.74%)
MSFT   227.96 (+0.54%)
FB   259.61 (+0.76%)
GOOGL   2,060.09 (+1.29%)
TSLA   591.09 (-4.88%)
AMZN   2,960.89 (-0.56%)
NVDA   485.01 (-1.98%)
BABA   232.68 (+0.95%)
CGC   29.95 (-3.42%)
GE   13.58 (+0.07%)
MU   84.76 (+0.51%)
NIO   36.34 (-7.48%)
AMD   76.86 (-1.14%)
T   29.57 (+2.25%)
F   12.12 (+1.59%)
ACB   9.39 (-4.38%)
DIS   187.00 (-0.55%)
BA   223.29 (-0.63%)
NFLX   503.62 (-1.50%)
BAC   36.95 (+1.23%)
S&P 500   3,766.78 (-0.04%)
DOW   31,007.17 (+0.27%)
QQQ   302.40 (-0.56%)
AAPL   119.24 (-0.74%)
MSFT   227.96 (+0.54%)
FB   259.61 (+0.76%)
GOOGL   2,060.09 (+1.29%)
TSLA   591.09 (-4.88%)
AMZN   2,960.89 (-0.56%)
NVDA   485.01 (-1.98%)
BABA   232.68 (+0.95%)
CGC   29.95 (-3.42%)
GE   13.58 (+0.07%)
MU   84.76 (+0.51%)
NIO   36.34 (-7.48%)
AMD   76.86 (-1.14%)
T   29.57 (+2.25%)
F   12.12 (+1.59%)
ACB   9.39 (-4.38%)
DIS   187.00 (-0.55%)
BA   223.29 (-0.63%)
NFLX   503.62 (-1.50%)
BAC   36.95 (+1.23%)
S&P 500   3,766.78 (-0.04%)
DOW   31,007.17 (+0.27%)
QQQ   302.40 (-0.56%)
AAPL   119.24 (-0.74%)
MSFT   227.96 (+0.54%)
FB   259.61 (+0.76%)
GOOGL   2,060.09 (+1.29%)
TSLA   591.09 (-4.88%)
AMZN   2,960.89 (-0.56%)
NVDA   485.01 (-1.98%)
BABA   232.68 (+0.95%)
CGC   29.95 (-3.42%)
GE   13.58 (+0.07%)
MU   84.76 (+0.51%)
NIO   36.34 (-7.48%)
AMD   76.86 (-1.14%)
T   29.57 (+2.25%)
F   12.12 (+1.59%)
ACB   9.39 (-4.38%)
DIS   187.00 (-0.55%)
BA   223.29 (-0.63%)
NFLX   503.62 (-1.50%)
BAC   36.95 (+1.23%)
S&P 500   3,766.78 (-0.04%)
DOW   31,007.17 (+0.27%)
QQQ   302.40 (-0.56%)
AAPL   119.24 (-0.74%)
MSFT   227.96 (+0.54%)
FB   259.61 (+0.76%)
GOOGL   2,060.09 (+1.29%)
TSLA   591.09 (-4.88%)
AMZN   2,960.89 (-0.56%)
NVDA   485.01 (-1.98%)
BABA   232.68 (+0.95%)
CGC   29.95 (-3.42%)
GE   13.58 (+0.07%)
MU   84.76 (+0.51%)
NIO   36.34 (-7.48%)
AMD   76.86 (-1.14%)
T   29.57 (+2.25%)
F   12.12 (+1.59%)
ACB   9.39 (-4.38%)
DIS   187.00 (-0.55%)
BA   223.29 (-0.63%)
NFLX   503.62 (-1.50%)
BAC   36.95 (+1.23%)
Log in
LON:FUM

Futura Medical Share Forecast, Price & News

GBX 20
-1.00 (-4.76 %)
(As of 03/5/2021 03:37 PM ET)
Add
Compare
Today's Range
19
Now: GBX 20
21.50
50-Day Range
13
MA: GBX 15.13
20.50
52-Week Range
7.16
Now: GBX 20
24.49
Volume724,093 shs
Average Volume847,913 shs
Market Capitalization£49.13 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Futura Medical plc, a pharmaceutical company, researches and develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual health and pain relief management. The company offers CSD500, a condom that contains erectogenic gel. It is also developing MED3000, a topical gel for the treatment of erectile dysfunction that has completed Phase III clinical trials. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical logo

Headlines

Futura Medical PLC Registered S (GYX.SG)
October 9, 2020 |  au.finance.yahoo.com
Futura Medical PLC
March 7, 2020 |  www.barrons.com
Futura Medical Regulatory News
January 17, 2020 |  www.lse.co.uk
Futura Medical Share Chat
January 8, 2020 |  www.lse.co.uk
Is Futura Medical plc's (LON:FUM) CEO Being Overpaid?
September 13, 2019 |  finance.yahoo.com
Is Futura Medical plc's (LON:FUM) CEO Being Overpaid?
September 13, 2019 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1483-685670
Employees13
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£31,778.00
Cash FlowGBX 1.05 per share
Book ValueGBX 0.90 per share

Profitability

Miscellaneous

Market Cap£49.13 million
Next Earnings Date3/29/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.16 out of 5 stars

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 20
-1.00 (-4.76 %)
(As of 03/5/2021 03:37 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FUM News and Ratings via Email

Sign-up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Futura Medical (LON:FUM) Frequently Asked Questions

Is Futura Medical a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Futura Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Futura Medical stock.
View analyst ratings for Futura Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Futura Medical?

Wall Street analysts have given Futura Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Futura Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Futura Medical's next earnings date?

Futura Medical is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Futura Medical
.

How were Futura Medical's earnings last quarter?

Futura Medical plc (LON:FUM) posted its earnings results on Wednesday, September, 16th. The company reported ($0.44) earnings per share (EPS) for the quarter.
View Futura Medical's earnings history
.

How has Futura Medical's stock price been impacted by Coronavirus?

Futura Medical's stock was trading at GBX 11.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FUM stock has increased by 79.8% and is now trading at GBX 20.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for FUM?

1 analysts have issued 12 month target prices for Futura Medical's stock. Their forecasts range from GBX 55 to GBX 55. On average, they expect Futura Medical's share price to reach GBX 55 in the next year. This suggests a possible upside of 175.0% from the stock's current price.
View analysts' price targets for Futura Medical
or view top-rated stocks among Wall Street analysts.

Who are Futura Medical's key executives?

Futura Medical's management team includes the following people:
  • Mr. James Henry Barder, CEO & Exec. Director (Age 61, Pay $238.25k)
  • Ms. Angela Hildreth, COO, Fin. Director, Company Sec. & Director
  • Mr. Kenneth William James, Head of R&D & Exec. Director (Age 68, Pay $172.79k)
  • Dr. William Duncan Potter, Chief Scientific Officer & Adviser to the Board (Age 73)

Who are some of Futura Medical's key competitors?

What other stocks do shareholders of Futura Medical own?

What is Futura Medical's stock symbol?

Futura Medical trades on the London Stock Exchange (LON) under the ticker symbol "FUM."

How do I buy shares of Futura Medical?

Shares of FUM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Futura Medical's stock price today?

One share of FUM stock can currently be purchased for approximately GBX 20.

How much money does Futura Medical make?

Futura Medical has a market capitalization of £49.13 million and generates £31,778.00 in revenue each year.

How many employees does Futura Medical have?

Futura Medical employs 13 workers across the globe.

What is Futura Medical's official website?

The official website for Futura Medical is www.futuramedical.com.

Where are Futura Medical's headquarters?

Futura Medical is headquartered at 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom.

How can I contact Futura Medical?

Futura Medical's mailing address is 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom. The company can be reached via phone at +44-1483-685670.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.